ResearchOct 1, 2026 · 02:372 sources
HHS Launches AI Program to Cut Drug Trial Costs by 10x
From marketbrief.now
The Department of Health and Human Services and ARPA-H have created SURPASS, an initiative using artificial intelligence to streamline clinical trials and reduce expenditures. The program will test automation to reduce operational delays, real-time analysis during active trials, and "phaseless" trial designs that require fewer patients. HHS estimates that current drug development takes more than a decade, costs around $2B per drug, and has a failure rate exceeding 90%, while ARPA-H targets a new framework that cuts these development costs by up to 10x and reduces timelines by at least half.
Read the sourceSign in to suggest
Sources
One ranked edition, every morning
The stories that matter today. Free, cancel anytime.
Telegram @aidr_today